COMPOSITIONS AND METHODS OF USING PROISLET PEPTIDES AND ANALOGS THEREOF

• 收藏
• 分享

专利权人:

LLC;CUREDM GROUP HOLDINGS

发明人:

LEVETAN, CLARESA S

申请号：

NZ59975508

公开号：

NZ599755A

申请日:

2008.08.29

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

Discloses a proislet peptide comprising an optimization modification, wherein said optimization modification is a C-terminal cysteine residue, wherein said peptide is selected from: modified HIP1,HIP2,HIP3, human REG3A/REG3G, human REGlA/REGIB, human REG4, hamster INGAP, hamster REG2, rodent REG3G, rat REGl, rat PAP/REG3B, rat PAP3, mouse REG l/REG2/REG3A/REG3B /REG3G/REG3S/REG4 peptides and bovine PTP peptide. Further discloses a optimization modification that is N-terminal acetyl group and a C terminal cysteine residue. Further disclosed is the use of disclosed peptides in the manufacture of a pharmaceutical composition for treating a pathology associated with impaired pancreatic function (e.g. diabetes).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/